Literature DB >> 1185165

Degenerative processes after punctate intracerebral administration of 6-hydroxydopamine.

L L Butcher.   

Abstract

Various doses of the neurotoxin 6-hydroxydopamine (6-OHDA) were infused into the substantia nigra-ventromedial tegmental area, caudateputamen nucleus, and red nucleus. A maximum of four successively occurring zones of neuropathology could by detected at all injection sites: (1) A zone of complete absence of neural, glial, and vascular elements due to tissue displacement by the cannula, (2) an area of glial cells, developing over time, which surrounded the cannula tract, (3) a region exhibiting virtually complete loss of neuronal elements, and (4) a zone of selective neuropathological reaction or cellular loss in which some neurons were affected and others were not. All investigators who have histochemically and/or histologically evaluated the effects of intracerebrally administered 6-OHDA agree on the existence and genesis, some non-selective process, of the first three zones. Although some scientists maintain that the fourth zone is where 6-OHDA operates selectively, data are presented in this report that other, well-established processes can account for neuropathology beyond zone 3. Prominent among these are retrograde and anterograde degeneration, ischemia as a function of interruption of blood supply, and nonselective traumatization. In addition, the topography of the injected site (e.g., morphology of affected neurons, degree of myelination) was found to be as important a determinant of the locus of tissue damage as the presumed selectivity of 6-OHDA's action. Furthermore, monoamine oxidase inhibition by nialamide did not appear to increase the neurotoxicity of 6-OHDA. Similarly, 1-(2,5-dihydroxy-4-methylphenyl)-2-aminopropane was not a more potent cytotoxin than 6-OHDA even though this new neurotoxin has a propane side chain which renders it immune to monoamine oxidase. These observations, taken together, suggest that considerable cautioon should be exercised in interpreting data from experiments in which 6-OHDA, or related neurotoxins, are used to uncover catecholaminergic mechanisms of behavior and other functional processes.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1185165     DOI: 10.1007/bf01670128

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  19 in total

1.  Localization of acetylcholinesterase within dopamine containing neurons in the zona compacta of the substantia nigra.

Authors:  L L Butcher; K Talbot; L Bilezikjian
Journal:  Proc West Pharmacol Soc       Date:  1975

2.  EVIDENCE FOR THE EXISTENCE OF MONOAMINE-CONTAINING NEURONS IN THE CENTRAL NERVOUS SYSTEM. I. DEMONSTRATION OF MONOAMINES IN THE CELL BODIES OF BRAIN STEM NEURONS.

Authors:  A DAHLSTROEM; K FUXE
Journal:  Acta Physiol Scand Suppl       Date:  1964

3.  The fine structure of the neurons in the rat substantia nigra.

Authors:  R L Gulley; R L Wood
Journal:  Tissue Cell       Date:  1971       Impact factor: 2.466

4.  Degenerative and nondegenerative effects of 6-hydroxydopamine on adrenergic nerves.

Authors:  G Jonsson; C Sachs
Journal:  J Pharmacol Exp Ther       Date:  1972-03       Impact factor: 4.030

5.  Anatomical and chemical studies of a nigro-neostriatal projection in the cat.

Authors:  R Y Moore; R K Bhatnagar; A Heller
Journal:  Brain Res       Date:  1971-07-09       Impact factor: 3.252

6.  Chemical sympathectomy by selective destruction of adrenergic nerve endings with 6-Hydroxydopamine.

Authors:  H Thoenen; J P Tranzer
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1968

7.  Specificity of 6-hydroxydopamine induced degeneration of central monoamine neurones: an electron and fluorescence microscopic study with special reference to intracerebral injection on the nigro-striatal dopamine system.

Authors:  T Hökfelt; U Ungerstedt
Journal:  Brain Res       Date:  1973-10-12       Impact factor: 3.252

8.  Injection of 6-hydroxydopamine in the substantia nigra of the rat. I. Morphological study.

Authors:  C Sotelo; F Javoy; Y Agid; J Glowinski
Journal:  Brain Res       Date:  1973-08-30       Impact factor: 3.252

9.  Selective action of 6-hydroxydopa on noradrenergic terminals: mapping of preterminal axons of the brain.

Authors:  D Jacobowitz; R Kostrzewa
Journal:  Life Sci I       Date:  1971-12-01

10.  Inhibition of biogenic amine uptake by hydrogen peroxide: a mechanism for toxic effects of 6-hydroxydopamine.

Authors:  R Heikkila; G Cohen
Journal:  Science       Date:  1971-06-18       Impact factor: 47.728

View more
  2 in total

1.  Effects of the noradrenaline neurotoxin N-2-chloroethyl-N-ethyl-2-bromo-benzylamine hydrochloride (DSP4) on the blood-brain barrier. An experimental study in the mouse using protein tracer and density determination techniques.

Authors:  C Tengvar; C A Pettersson; A K Mohammed; Y Olsson
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

2.  Pars compacta of the substantia nigra modulates motor activity but is not involved importantly in regulating food and water intake.

Authors:  G K Hodge; L L Butcher
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-08       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.